Lytron-TZ 1000mg/125mg Injection
Marketer
Lichem Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Lytron-TZ 1000mg/125mg Injection
Combiflox-TZ 1000mg/125mg injectable solution is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration of Combiflox-TZ 1000mg/125mg Injection must be under a doctor's direct supervision. Complete the prescribed treatment regimen; don't miss doses. Premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek urgent medical attention for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications before initiating treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't impair driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, proper nutrition, and sufficient hydration contribute to faster recovery. Your doctor may order blood tests and other diagnostic evaluations to monitor treatment response.
Primary Ingredients of Lytron-TZ 1000mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Lytron-TZ 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Lytron-TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Lytron-TZ 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Lytron-TZ 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lytron-TZ 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam (Lytron-TZ 1000mg/125mg Injection) combines a cephalosporin antibiotic, Ceftriaxone, with a beta-lactamase inhibitor, Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Lytron-TZ 1000mg/125mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Lytron-TZ (1000mg/125mg) is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Lytron-TZ 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Lytron-TZ 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lytron-TZ 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Lytron-TZ (1000mg/125mg) requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Patients should seek medical advice. Dosage alteration for Lytron-TZ (1000mg/125mg) injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Lytron-TZ 1000mg/125mg Injection :
Omitting a scheduled dose of Lytron-TZ 1000mg/125mg Injection necessitates contacting your physician.
Facts to Know About Lytron-TZ 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |



